3-(Cyclopropylaminocarbonyl)Phenylboronic Acid: A Manufacturer's Perspective

Introduction to 3-(Cyclopropylaminocarbonyl)Phenylboronic Acid

3-(Cyclopropylaminocarbonyl)Phenylboronic Acid, often referenced in research and industry as a key intermediate, stands out in our lineup of boronic acid derivatives. Our team started developing this compound after repeated discussions with medicinal chemistry groups who often ran into bottlenecks with traditional phenylboronic acids, particularly in complex heterocycle design. We recognized a gap for a more versatile and stable boronic acid that would respond well under various coupling conditions, especially for Suzuki-Miyaura reactions that demand both precision and resilience in the reagent.

We manufacture this compound using a process honed through years of iterative refinement. Our approach favors purity, consistency, and reproducibility in every batch shipped out. Chemists on our team spent significant time optimizing reactions and work-up procedures that limit side product formation, especially cyclopropyl ring-opening, which can derail downstream synthesis. Each lot gets evaluated both by NMR and HPLC to ensure the cyclic amide group and boronic acid moiety hold up even in storage. We store and ship the acid under dry, inert conditions to preserve the fine, off-white solid as it leaves our facility.

Molecular Structure and Specifications

The structure of 3-(Cyclopropylaminocarbonyl)Phenylboronic Acid brings together two important chemical motifs. The boronic acid group on the phenyl ring offers classic reactivity for cross-coupling, while the ortho-cyclopropylaminocarbonyl substitution adds rigidity, electron-modulating effects, and unique hydrogen bonding interactions. Chemists searching for new scaffolds to test biological activity on kinases and proteases often turn to this compound because the cyclopropyl unit tweaks both sterics and electronics in a way that common alkyl chains or aryls don't replicate. Every gram we produce comes with full analytical data—our in-house lab uses LC-MS, NMR, and melting point analysis as part of routine quality control.

Our chemical is supplied in the form of a pale, free-flowing powder. The product dissolves well in polar aprotic solvents including DMF, DMSO, and acetonitrile, ideal for handling in both small-scale library synthesis and larger pilot runs. Water content is kept low to prevent premature hydrolysis, and each drum or vial includes a desiccant for transport.

Our Experience with Synthesis and Scale-Up

Scaling up this class of boronic acids presented challenges unique to the fused cyclopropyl ring and the carbamoyl group. Our chemists encountered side reactions at elevated temperatures, so we developed a gentle, controlled approach to cyclopropylation. The downstream boronation uses organometallics in a temperature-staged protocol. Direct feedback from our purification team pushed us to refine the crystallization step, ensuring consistent yields and easy filtration. By analyzing mother liquors from early runs, we discovered a few minor byproducts that taught us more about the process conditions—now, those impurities are kept below threshold in each lot.

Our own R&D group has trialed the acid on a variety of coupling partners, finding that the cyclopropyl amide group resists cleavage even in basic media. That durability saves time for chemists conducting lengthy reaction sequences since the core functionality survives multiple steps.

Application in Medicinal Chemistry

This boronic acid earned its place in our portfolio after we noticed how often research teams in oncology, neuroscience, and anti-infectives requested variations on this structure. Modern drug discovery screens thousands of analogs, needing reliable building blocks for structure-activity relationship studies. Here, the cyclopropylaminocarbonyl group adds size and electron density without introducing labile esters or long alkyl chains, keeping the resulting molecules both robust and biologically interesting.

In our manufacturing role, we keep in close contact with customers. Some shared that 3-(Cyclopropylaminocarbonyl)Phenylboronic Acid performed better than basic phenylboronic acid when creating biaryl scaffolds—they saw fewer side products derived from ring fragmentation or unwanted amide hydrolysis. The boronic acid's position on the ring appears to improve compatibility with both electron-rich and electron-poor partners, a key need for those building compound libraries.

We have worked with teams developing proteasome inhibitors and kinase inhibitors. The cyclopropyl group influences how inhibitors fit into enzyme pockets, sometimes flipping the structure-activity profile compared to straight-chain analogs. Stability during the cross-coupling, combined with reliable reactivity, has led customers to standardize this building block in several discovery programs. They benefit from high-purity lots and traceable documentation for regulatory filings. Stability data show that the acid resists aerial oxidation when sealed, a definite asset compared to related boronic acids that can lattice or degrade under room air.

Bench Handling and Safety Notes

During development, our technical staff observed that this boronic acid behaves somewhat differently than simpler analogs. The cyclopropyl unit adds some volatility to the initial intermediate, but by the time we furnish the final product, it handles easily. We recommend gloves and standard lab precautions in line with handling of fine boronic acids. Unlike many boronic esters, the acid form here resists exothermic decomposition and doesn’t produce problematic odors, so it fits cleanly into most process laboratories.

Product loss to sublimation or dusting proved minimal after optimizing particle size, which results in smooth, controlled weighing even down to the milligram scale. We also found that the substance can be stored in polypropylene or glass, provided it remains sealed and protected from atmospheric moisture.

Comparing Alternatives and Learning from Experience

We manufacture several phenylboronic acids with a mix of substitutions: methoxy, halogen, straight chain carbamoyl, and more. The cyclopropylaminocarbonyl group sets this compound apart through its impact on molecular shape and chemical stability. Chemists using isopropyl or tert-butyl counterparts often call to talk about solubility or hydrolysis issues. Our product brings higher resistance to hydrolytic breakdown, which extends shelf life during storage and shipment.

Downstream reactions often ask much of the boronic acid. Variations without the cyclopropyl unit show slightly faster rates in aqueous media, but researchers report improved selectivity and yield with our compound under comparable conditions. The rigidity of the cyclopropyl ring blocks rotational freedom that sometimes causes side reactions with more flexible, alkyl-substituted derivatives.

Colleagues in process chemistry pointed out that the chemical robustness of this molecule allows their teams to experiment with wider temperature ranges, and to try both batch and continuous flow synthetic methods. That flexibility isn’t just academic; it opens new paths for process improvement and scale-up.

Sustainability and Waste Management

Running a responsible manufacturing operation doesn’t stop with production. We invested in waste-stream management that prevents carryover of boronic acid residues into aqueous wastes. Early on, we saw that not all suppliers in the market neutralize boronic wastes thoroughly, creating environmental compliance headaches for down-the-line customers. Our facility runs a closed-system recovery cycle that grabs spent boronic acids for safe disposal, keeping our operation aligned with best practices and regulatory expectations. Both our plant and end customers can avoid the long-term ecological problems sometimes associated with boron compounds.

Solvent recycling and in-process energy efficiency are front and center in our site’s operation protocols. Our research into greener coupling protocols, including use of water or low-toxicity solvents where compatible, continues. Being a chemical manufacturer means accountability for the full lifecycle of a product, and our own audit teams track each batch from starting material to finished goods and on to eventual recycling of drums and containers.

Customer Partnership and Continuous Improvement

From our own discussions with clients, we know that a reliable supply chain, detailed technical support, and attention to regulatory documentation build strong partnerships. Each year, we adjust our procedures based on customer input—sometimes as simple as shifting packaging sizes to suit academic labs, or as complex as modifying particle size distributions for automated weighing systems in production settings.

Pharmaceutical customers often ask about batch traceability, especially for submissions to health authorities. We maintain detailed batch records and can supply full analytical data on request. Years of commitment to cleanroom protocols, regular audits, and dedicated documentation have made us a trusted partner, not only for high-throughput screening but also for molecules destined for clinical development.

Our Take on Industry Trends

The landscape for boronic acids keeps changing. Advances in cross-coupling chemistry push us to develop new derivatives every year. We stay close to academic labs and larger pharmaceutical companies to anticipate shifting needs, whether for more electron-rich building blocks, novel heterocycles, or faster-reacting boronic acids. Our teams attend conferences, scan the latest literature, and check market feedback. Knowledge gained from manufacturing this cyclopropylaminocarbonyl compound has taught us about what matters most—steady performance, clear documentation, and a willingness to adapt based on user feedback.

Drug discovery cycles have grown shorter. Projects that once moved at a measured pace now demand rapid turnaround of novel building blocks. Our systems prioritize both agility and integrity—through careful planning, advanced analytical equipment, and robust process controls. While there’s no one-size-fits-all answer in synthetic chemistry, our experience tells us that investing in molecule-specific process optimization pays lasting dividends for both us and our customers.

Looking Forward

3-(Cyclopropylaminocarbonyl)Phenylboronic Acid has outperformed expectations since we brought it to market. Demand from innovative R&D teams signals that this scaffold remains highly valued in modern chemical design. Our attention to detail, willingness to engage with customer problems, and promise to deliver on schedule continue to shape how we make and distribute this compound. For those exploring new frontiers in medicinal chemistry, process development, or chemical biology, our firsthand experience positions us as both partner and resource in ongoing discovery efforts.

Every new request or inquiry about this compound, whether for a kilo-scale campaign or a screening set, gives us an opportunity to learn and improve. This steady cycle—listening, evolving, and refining—stands as the foundation of our work. By maintaining close ties to those advancing science in the lab, we help realize the full potential of compounds like 3-(Cyclopropylaminocarbonyl)Phenylboronic Acid, anchoring innovation on a legacy of manufacturing expertise.